Virun closes funding for global expansion

After almost 10 years of self-funding growth and business expansion, Virun is now capitalising on its patented technology portfolio and product development.

Virun has successfully raised $2.1m from Bluestem, a private equity firm, in addition to private investors.

The financing closed mid-July following the successful obtainment of several notices of allowances and patent grants for key technologies in the area of food, beverage, consumer products and pharmaceuticals.

Source: Virun

.